Suppression mediated by anergic CD4+ T cells requires stimulation by MHC-peptide complexes and can be induced in the presence of costimulation

Transplantation

Volumn 72, Issue 3, 2001, Pages 369-376

  Witzke, Oliver ^a   Wheeler, Paul R ^a   Barbara, Jeffrey A J ^a   Gaspar, Manuela Carvalho ^a   Morris, Peter J ^a   Wood, Kathryn J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY CD3; PEPTIDE;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CELL CULTURE; CELL STIMULATION; CLONAL ANERGY; COMPLEX FORMATION; CONTROLLED STUDY; DOWN REGULATION; IMMUNOCOMPETENT CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE; TH1 CELL;

EID: 0035882089     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200108150-00004     Document Type: Article

References (46)

1. Extrathymic tolerance of mature T cells: Clonal elimination as a consequence of immunity
2. Peripheral deletion of antigen-reactive T cells in oral tolerance
3. Antigen-specific down-regulation of myelin basic protein-reactive T cells during spontaneous recovery from experimental autoimmune encephalomyelitis: Further evidence of apoptotic deletion of autoreactive T cells in the central nervous system
4. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice
5. Anergy and exhaustion are independent mechanisms of peripheral T cell tolerance
6. Long life span of tolerant T cells and the role of antigen in maintenance of peripheral tolerance
7. "Infectious" transplantation tolerance
8. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: Suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells
9. Regulatory T cells in maintenance and reversal of peripheral tolerance in vivo
10. Anergic T cells as suppressor cells in vitro
11. Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II-restricted T cells anergized in vive
12. Anergic T cells act as suppressor cells in vitro and in vivo
13. Thymus and autoimmunity: Production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance
14. Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody
15. Dose-dependent induction of distinct anergic phenotypes: Multiple levels of T cell anergy
16. T-cell anergy induced by clonotype-specific antibodies: Modulation of an autoreactive human T-cell clone in vitro
17. Models of T cell anergy: Is there a common molecular mechanism
18. Immobilized anti-CD3 mAb induces anergy in murine naive and memory CD4+ T cells in vitro
19. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells
20. Induction of T cell unresponsiveness by anti-CD3 antibodies occurs independently of co-stimulatory functions
21. Clonal anergy is induced in vitro by T cell receptor occupancy in the absence of proliferation
22. Molecular regulation of interleukin-2 expression by CD28 co-stimulation and anergy
23. Mechanisms of peripheral tolerance and suppression induced by monoclonal antibodies to CD4 and CD8
24. T cell suppression in transplantation tolerance through linked recognition
25. Anergic T cells effect linked suppression
26. Pretransplant administration of a single donor class I major histocompatibility complex molecule is sufficient for the indefinite survival of fully allogeneic cardiac allografts: Evidence for linked epitope suppression
27. Anergic T cells actively suppress T cell responses via the antigen-presenting cell
28. Anergic TH1 clones specific for hepatitis B virus (HBV) core peptides are inhibitory to other HBV core-specific CD4+ T cells in vitro
29. Identification of a monoclonal antibody specific for a murine T3 polypeptide
30. Identification and distribution of the costimulatory receptor CD28 in the mouse
31. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones
32. The role of B7-1/B7-2:CD28/CLTA-4 pathways in the prevention of anergy, induction of productive immunity and down-regulation of the immune response
33. B7-mediated costimulation and the immune response
34. B7-blocking agents, alone or in combination with cyclosporin A, induce antigen-specific anergy of human memory T cells
35. Transplantation of anergic histoincompatible bone marrow allografts
36. Clonal analysis of differential lymphokine production in peptide and superantigen induced T cell anergy
37. Induction of anergy in human T helper 0 cells by stimulation with altered T cell antigen receptor ligands
38. Reversal of in vitro T cell clonal anergy by IL-2 stimulation
39. Allogeneic non-T spleen cells restore the responsiveness of normal T cell clones stimulated with antigen and chemically modified antigen-presenting cells
40. The yin and yang of T cell costimulation
41. Heart allografts in murine systems: The differential activation of Th2-like effector cells in peripheral tolerance
42. Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation
43. Cytokines and the Th1/Th2 paradigm in transplantation
44. Evidence for immune regulation in the induction of transplantation tolerance: A conditional but limited role for IL-4
45. TCR-Mediated internalization of peptide-MHC complexes acquired by T cells
46. Major histocompatibility complex-based suppression: A mechanism for T-cell control